
|Articles|April 1, 2002
- Volume 0 0
Early and Aggressive Intervention in RA Crucial
Advertisement
A recent study conducted at Turku University in Finland highlights the urgency of early and aggressive treatment of rheumatoid arthritis (RA). The study examined the impact of delaying treatment for symptoms on whether disease remission is achieved; it also assessed the efficacy of single-drug therapy vs combination therapy. Researchers found that those in the group whose treatment was delayed fared worst, whereas those who received an aggressive combination-therapy regimen fared best.
Articles in this issue
over 24 years ago
Blood Pressure Drugs May Improve Fitness in the Elderlyover 24 years ago
Fast Facts on Osteoporosisover 24 years ago
Take Tea and See?Higher Bone Densityover 24 years ago
New Fish Advisory Coming for Pregnant Womenover 24 years ago
Fitness Mattersover 24 years ago
Systolic Measurement Better Indicator of Mortality Riskover 24 years ago
Higher Activity = Lower Blood Pressureover 24 years ago
Juan Valdez and Starbucks Would Smileover 24 years ago
ASTHMA Underdiagnosed and Undertreatedover 24 years ago
Pharmacists Important Asthma CounselorsAdvertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients
2
Pharmacists Are Critical to SGLT2, GLP-1 Use in CKD
3
Why COVID-19 Prevention Still Matters During 2026's Summer Surge
4
FDA Expands Lutetium Lu 177 Vipivotide Tetraxetan to mHSPC, Nearly Doubling Eligible Population
5






































































































